We are live on ! Find out more
PCA

Peddock Capital Advisors Portfolio holdings

AUM $501M
1-Year Est. Return 29.8%
This Fund
S&P 500
This Quarter Est. Return
-0.9%
1 Year Est. Return
+29.8%
3 Year Est. Return
+104.15%
5 Year Est. Return
+160.2%
10 Year Est. Return
+350.74%
AUM
$163M
AUM Growth
+$5.92M
Cap. Flow
+$9.26M
Cap. Flow %
5.69%
Top 10 Hldgs %
60.86%
Holding
245
New
153
Increased
38
Reduced
12
Closed
2

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$1.49M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$966K
3
MA icon
Mastercard
MA
+$396K
4
HPQ icon
HP
HPQ
+$353K
5
CF icon
CF Industries
CF
+$308K

Sector Composition

Rank Sector Weight
1 Energy 48.04%
2 Healthcare 7.93%
3 Technology 7.04%
4 Financials 6.14%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCTY
201
DELISTED
SolarCity Corporation
SCTY
$15K 0.01%
+750
New +$16.8K
HSIC icon
202
Henry Schein
HSIC
$9.74B
$14K 0.01%
+219
New +$14.5K
PSX icon
203
Phillips 66
PSX
$82.9B
$11K 0.01%
+138
New +$10.7K
AVGO icon
204
Broadcom
AVGO
$1.82T
$10K 0.01%
+600
New +$10K
CTSH icon
205
Cognizant
CTSH
$21.5B
$10K 0.01%
+200
New +$11.4K
EVV
206
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
$10K 0.01%
+700
New +$9.56K
AMCC
207
DELISTED
Applied Micro Circuits Corporation New
AMCC
$10K 0.01%
+1,500
New +$10.4K
PAYX icon
208
Paychex
PAYX
$40.4B
$9K 0.01%
+150
New +$8.99K
AMCX icon
209
AMC Global Media
AMCX
$430M
$8K ﹤0.01%
+154
New +$8.44K
SYF icon
210
Synchrony
SYF
$23.7B
$8K ﹤0.01%
+269
New +$7.39K
HES
211
DELISTED
Hess
HES
$7K ﹤0.01%
+130
New +$6.97K
CDK
212
DELISTED
CDK Global, Inc.
CDK
$5K ﹤0.01%
+83
New +$4.78K
MCRB icon
213
Seres Therapeutics
MCRB
$48M
$4K ﹤0.01%
+15
New +$5.26K
NOK icon
214
Nokia
NOK
$50.8B
$4K ﹤0.01%
+726
New +$4.12K
HSY icon
215
Hershey
HSY
$35.4B
$3K ﹤0.01%
+34
New +$3.6K
IJS icon
216
iShares S&P Small-Cap 600 Value ETF
IJS
$8.11B
$3K ﹤0.01%
+44
New +$2.7K
MUSA icon
217
Murphy USA
MUSA
$11.3B
$3K ﹤0.01%
+36
New +$2.69K
SRPT icon
218
Sarepta Therapeutics
SRPT
$1.66B
$3K ﹤0.01%
+54
New +$1.63K
VCIT icon
219
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$3K ﹤0.01%
+35
New +$3.13K
CST
220
DELISTED
CST Brands, Inc.
CST
$3K ﹤0.01%
+55
New +$2.53K
CYTK icon
221
Cytokinetics
CYTK
$11B
$2K ﹤0.01%
+261
New +$2.73K
TSLA icon
222
Tesla
TSLA
$1.24T
$2K ﹤0.01%
+150
New +$2.17K
V icon
223
Visa
V
$677B
$2K ﹤0.01%
+28
New +$2.24K
NBSE
224
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$2K ﹤0.01%
+1
New +$1.08K
AFL icon
225
Aflac
AFL
$63.9B
$1K ﹤0.01%
+26
New +$946

Similar funds

Peddock Capital Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Peddock Capital Advisors held 245 positions worth $163M, up 3.8% from $157M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Peddock Capital Advisors deployed $9.26M of net new capital in Q3 2016, opening 153 new positions and adding to 38 existing holdings. Its largest new stake was Allergan Inc: 6,483 shares worth $1.49M.

By sector, the portfolio is most concentrated in Energy at 48% of assets, down from 55% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was ExxonMobil, an estimated $2.42M trimmed.

  • Peddock Capital Advisors's largest Q3 2016 buy was Allergan Inc: 6,483 shares worth $1.49M.
  • Peddock Capital Advisors added most to Mastercard in Q3 2016, an estimated $396K increase.
  • Peddock Capital Advisors's biggest Q3 2016 reduction was ExxonMobil, cutting an estimated $2.42M.
  • Peddock Capital Advisors fully exited Procter & Gamble in Q3 2016, selling an estimated $1.84M.
  • Peddock Capital Advisors's ten largest holdings make up 61% of its $163M portfolio in Q3 2016.
  • Peddock Capital Advisors opened 153 new positions and closed 2 in Q3 2016.
  • Peddock Capital Advisors's portfolio value rose 3.8% quarter-over-quarter to $163M.

Based on Peddock Capital Advisors's 13F filing for Q3 2016, filed 14 Oct 2016.